Abstract
The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design is discussed below.
Keywords: vip receptors, vip, vasoactive intestinal peptide, drug design, vip family
Current Pharmaceutical Design
Title: VIP and Drug Design
Volume: 9 Issue: 6
Author(s): Illana Gozes and Sharon Furman
Affiliation:
Keywords: vip receptors, vip, vasoactive intestinal peptide, drug design, vip family
Abstract: The following review outlines the physiological outcome of VIP and VIP gene manipulations. Previously, we reviewed the various VIP receptors associated with biological functions ranging from growth regulation, sexual function, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP-based drug design is discussed below.
Export Options
About this article
Cite this article as:
Gozes Illana and Furman Sharon, VIP and Drug Design, Current Pharmaceutical Design 2003; 9 (6) . https://dx.doi.org/10.2174/1381612033391667
DOI https://dx.doi.org/10.2174/1381612033391667 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systems Biology and Personalized Medicine in Cancer
Current Pharmacogenomics and Personalized Medicine Antidepressants: Current Strategies and Future Opportunities
Current Pharmaceutical Design Potential Non-coding RNAs from Microorganisms and their Therapeutic Use in the Treatment of Different Human Cancers
Current Gene Therapy Meet the Editorial Board:
Current Medicinal Chemistry Potential Therapeutic Targets for Steroid-Resistant Asthma
Current Drug Targets Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry Toxicity of Magnetic Resonance Imaging Agents: Small Molecule and Nanoparticle
Current Topics in Medicinal Chemistry Function and Regulation of Let-7 Family microRNAs
MicroRNA Erectile Dysfunction as a Cardiovascular Risk Factor: Time to Step Up?
Current Vascular Pharmacology Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Design, Synthesis and Antiproliferative Activity of 2-Acetamidothiazole-5- carboxamide Derivatives
Medicinal Chemistry Immunotherapy for Conformational Diseases
Current Pharmaceutical Design Germinal and Somatic Trisomy 21 Mosaicism: How Common is it, What are the Implications for Individual Carriers and How Does it Come About?
Current Genomics Second Generation Proteasome Inhibitors: Carfilzomib and Immunoproteasome-Specific Inhibitors (IPSIs)
Current Cancer Drug Targets Mirware: A MiRNA-mRNA Warehouse for Inference on Their Coordination
MicroRNA On the Comparison of Classifiers for Microarray Data
Current Bioinformatics Genome-Wide Analysis of Low Dose Bisphenol-A (BPA) Exposure in Human Prostate Cells
Current Genomics Melatonin, Autophagy and Intestinal Bowel Disease
Current Pharmaceutical Design Modulation of MicroRNAs by <i>Euphorbia Microsciadia</i> Boiss in MDA-MB-231 Cell Line: New Possibilities in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Recent Developments of DNA Poisons - Human DNA Topoisomerase IIα Inhibitors - as Anticancer Agents
Current Pharmaceutical Design